Complete Filing Data
WEN Acquisition Corp reported Net Income Loss of $6.88 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean WEN Acquisition Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Income Loss | $6.9M |
| Operating Income Loss | -$756.7K |
| General And Administrative Expense | $756.7K |
| Payment Of General And Administrative Costs Through Promissory Note | $53.7K |
| Payment Of General And Administrative Costs Through Due To Sponsor | $5.5K |
| Other Nonoperating Income Expense | |
| Nonoperating Income Expense | |
| Payment Of Operating Expenses Through Promissory Note Related Party | |
| Other Nonoperating Income | $7.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Net Income Loss | $3.0M | $1.2M | -$43.9K |
| Operating Income Loss | -$258.2K | -$229.0K | -$43.9K |
| General And Administrative Expense | $258.2K | $229.0K | $43.9K |
| Payment Of General And Administrative Costs Through Promissory Note | |||
| Payment Of General And Administrative Costs Through Due To Sponsor | |||
| Other Nonoperating Income Expense | $1.4M | ||
| Nonoperating Income Expense | $3.3M | ||
| Payment Of Operating Expenses Through Promissory Note Related Party | $38.3K | ||
| Other Nonoperating Income |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Stockholders Equity | -$13.7M |
| Temporary Equity Accretion To Redemption Value | $30.3M |
| Retained Earnings Accumulated Deficit | -$13.7M |
| Liabilities And Stockholders Equity | $308.5M |
| Liabilities | $14.4M |
| Deferred Offering Costs Included In Accrued Offering Cost | $75.0K |
| Deferred Offering Cost Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 25.0K |
| Assets Current | $681.5K |
| Assets | $308.5M |
| Accrued Offering Costs Current | $75.0K |
| Accounts Payable And Accrued Liabilities Current | $50.9K |
| Prepaid Expense And Other Assets Current | $50.1K |
| Other Liabilities Current | $5.5K |
| Liabilities Current | $131.3K |
| Deferred Underwriting Fee Payable | $14.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $554.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $554.0K |
| Assets Held In Trust Noncurrent | $307.8M |
| Repayments Of Notes Payable | $300.0K |
| Deferred Offering Costs Paid Through IPO Promissory Note | $200.9K |
| Deferred Fee Payable | $14.3M |
| Deferred Costs |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Stockholders Equity | -$13.5M | -$13.2M | -$18.9K |
| Temporary Equity Accretion To Redemption Value | $3.3M | $24.0M | |
| Retained Earnings Accumulated Deficit | -$13.5M | -$13.2M | -$43.9K |
| Liabilities And Stockholders Equity | $305.8M | $302.7M | $94.8K |
| Liabilities | $14.4M | $14.4M | $113.8K |
| Deferred Offering Costs Included In Accrued Offering Cost | $26.1K | ||
| Deferred Offering Cost Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 25.0K | ||
| Assets Current | $914.5K | $1.1M | $12.3K |
| Assets | $305.8M | $302.7M | $94.8K |
| Accrued Offering Costs Current | $88.1K | $88.1K | $26.1K |
| Accounts Payable And Accrued Liabilities Current | $64.6K | $18.7K | $420.00 |
| Prepaid Expense And Other Assets Current | $74.2K | $108.8K | |
| Other Liabilities Current | $5.5K | $5.5K | |
| Liabilities Current | $158.1K | $112.2K | |
| Deferred Underwriting Fee Payable | $14.3M | $14.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $762.9K | $921.3K | |
| Assets Held In Trust Noncurrent | $304.8M | $301.6M | |
| Repayments Of Notes Payable | |||
| Deferred Offering Costs Paid Through IPO Promissory Note | |||
| Deferred Fee Payable | |||
| Deferred Costs | $82.5K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Increase Decrease In Accrued Liabilities | $50.9K |
| Proceeds From Issuance Of Private Placement | $7.2M |
| Proceeds From Issuance Of Common Stock | $294.9M |
| Payments To Acquire Investments | $300.2M |
| Payments Of Stock Issuance Costs | $386.1K |
| Net Cash Provided By Used In Operating Activities | -$759.9K |
| Net Cash Provided By Used In Investing Activities | -$300.2M |
| Net Cash Provided By Used In Financing Activities | $301.5M |
| Increase Decrease In Prepaid Insurance | $108.6K |
| Increase Decrease In Prepaid Expenses Other | $4.7K |
| Increase Decrease In Prepaid Expense |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 |
|---|---|
| Increase Decrease In Accrued Liabilities | $420.00 |
| Proceeds From Issuance Of Private Placement | |
| Proceeds From Issuance Of Common Stock | |
| Payments To Acquire Investments | |
| Payments Of Stock Issuance Costs | |
| Net Cash Provided By Used In Operating Activities | |
| Net Cash Provided By Used In Investing Activities | |
| Net Cash Provided By Used In Financing Activities | |
| Increase Decrease In Prepaid Insurance | |
| Increase Decrease In Prepaid Expenses Other | |
| Increase Decrease In Prepaid Expense | -$5.2K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Preferred Stock Shares Authorized | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 |
| Sale Of Stock Number Of Shares Issued In Transaction | 7.2M |
| Weighted Average Number Of Shares Issued Basic | |
| Earnings Per Share Diluted | |
| Earnings Per Share Basic |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Sale Of Stock Number Of Shares Issued In Transaction | 7.2M | ||
| Weighted Average Number Of Shares Issued Basic | 6.5M | ||
| Earnings Per Share Diluted | $-0.01 | ||
| Earnings Per Share Basic | $-0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Investment Income Interest | $7.6M |
| Stock Issued During Period Value New Issues | $25.0K |
| Sale Of Private Placement Warrants | $7.2M |
| Prepaid Insurance | $77.4K |
| Adjustments To Additional Paid In Capital Warrant Issued | $2.6M |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $193.7K |
| Prepaid Expense Noncurrent | $31.2K |
| Prepaid Services Contributed By Sponsor Through IPO Promissory Note | $45.5K |
| Prepaid Insurance Non Current | |
| Prepaid Expense Current | |
| Notes Issued1 | |
| Additional Paid In Capital |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Investment Income Interest | $3.3M | $1.4M | |
| Stock Issued During Period Value New Issues | $25.0K | ||
| Sale Of Private Placement Warrants | $7.2M | ||
| Prepaid Insurance | $77.4K | $76.3K | |
| Adjustments To Additional Paid In Capital Warrant Issued | $2.6M | ||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $193.7K | ||
| Prepaid Expense Noncurrent | $50.5K | ||
| Prepaid Services Contributed By Sponsor Through IPO Promissory Note | |||
| Prepaid Insurance Non Current | $70.9K | ||
| Prepaid Expense Current | $12.3K | ||
| Notes Issued1 | $31.5K | ||
| Additional Paid In Capital | $24.3K |
Most recent annual filing with the SEC: March 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.